Prehypertension: The rationale for early drug therapy

Cardiovascular Therapeutics

Volumn 28, Issue 6, 2010, Pages 339-343

  Fuchs, Flávio Danni ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Blood pressure lowering drugs; Prehypertension; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DRUG EFFICACY; EARLY INTERVENTION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREHYPERTENSION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; MIDDLE AGED; PREHYPERTENSION; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 78449231612     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00167.x     Document Type: Review

References (28)

1. World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization. 2002; Available from:. [Accessed 18 December 2009].
2. Law MR, Morris JK, Wald NJ,. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
3. Pereira M, Lunet N, Azevedo A, Barros H,. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27: 963 - 975.
4. Keith NM, Wegener HP, Barker NW,. Some different types of essential hypertension: Their course and prognosis. Am J Sci 1939; 197: 332 - 343.
5. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903 - 1913.
6. Hsia J, Margolis KL, Eaton CB, et al,. Women's Health Initiative Investigators. Pre-hypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007; 115: 855 - 860.
7. Russell LB, Valiyeva E, Carson JL,. Effects of pre-hypertension on admissions and deaths: A simulation. Arch Intern Med 2004; 164: 2119 - 2124.
8. Guyton AC, Coleman TG, Cowley AV Jr,., Scheel KW, Manning RD Jr,., Norman RA Jr,. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52: 584 - 594.
9. Tobian L,. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension 1991; 17 (Suppl 1): I52 - I58.
10. Dahl LK,. Salt intake and hypertension. In:, Genest J, Koiw E, Kuchel O, editors. Hypertension, New York: McGraw Hill, 1977; 548 - 559.
11. Folkow B, Hallback M, Lundgreen Y, Sivertsson R, Weiss L,. Importance of adaptative changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats. Circ Res 1973; 32 (Suppl I): 2 - 16.
12. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J,. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217 - 223.
13. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A,. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991; 17: 22 - 27.
14. Moreira LB, Fuchs SC, Wiehe M, Gus M, Moraes RS, Fuchs FD,. Incidence of hypertension in Porto Alegre, Brazil: A population-based study. J Hum Hypertens 2008; 22: 48 - 50.
15. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med 1997; 157: 657 - 667.
16. Appel LJ, Moore TJ, Obarzanek E, et al,. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117 - 1124.
17. Premier Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control. JAMA 2003; 289: 2083 - 2093.
18. Hooper L, Bartlett C, Davey Smith G, Ebrahim S,. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002; 325: 628.
19. Fuchs FD, Gus M, Moreira WD, et al,. Blood pressure effects of antyhypertensive drugs and lifestyle modification in a Brazilian hypertensive cohort. J Hypert 1997; 15: 783 - 792.
20. Julius S, Nesbitt S, Egan B, et al,. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685 - 1697.
21. Lüders S, Schrader J, Berger J, et al,. The PHARAO study: Prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure'a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens 2008; 26: 1487 - 1496.
22. Staessen JA, Wang JG, Thijs L,. Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001; 358: 1305 - 1315.
23. Staessen JA, Wang JG, Thijs L,. Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until March 2003. J Hypertens 2003; 21: 1055 - 1076.
24. Fuchs FD,. Blood pressure-lowering drugs: Essential therapy for some patients with normal blood pressure. Expert Rev Cardiovasc Ther 2004; 2: 89 - 93.
25. Fuchs FD,. The corporate bias and the molding of prescription practices: The case of hypertension. Braz J Med Biol Res 2009; 42: 224 - 228.
26. Fuchs FD,. Diuretics: Still essential drugs for the management of hypertension. Expert Rev Cardiovasc Ther 2009; 7: 591 - 598.
27. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB,. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35: 1025 - 1030.
28. Guerrero P, Fuchs FD, Moreira LM, Martins VM, Bertoluci C, Fuchs SC, Gus M,. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. Clin Exp Hypertens 2008; 30: 553 - 564.